Associations between low circulatory low-density lipoprotein cholesterol level and brain health in non-stroke non-demented subjects

ABSTRACT Low‐density lipoprotein cholesterol (LDL‐C) and hypertension have independent and synergistic effects on atherosclerotic cardiovascular disease. However, the role of circulatory LDL‐C and its possible interactions with hypertension in brain health have been poorly investigated. The study aimed to investigate the relationship between the circulatory LDL‐C level and (1) brain structures, grey‐matter volume (GMV) and white matter hyperintensity (WMH) and (2) cognitive functions, and whether hypertension plays a role in these relationships. Subjects who were non‐stroke and non‐demented were prospectively recruited from the community‐based I‐Lan Longitudinal Aging Study. High‐resolution 3T MRI was performed with GM and WMH segmentation. GMVs, total and regional including Alzheimer's disease‐susceptible area, and WMH volumes were measured. Neurological tests including verbal memory, visuospatial, and verbal executive functions were assessed. Eight‐hundred‐and‐two participants (59.2±5.7 years; 44% men) were included. Multivariate linear regression analyses showed that low circulatory LDL‐C levels (<98mg/dL) were significantly associated with reduced GMVs in frontal (standardized &bgr;=−0.130; p=0.003) and posterior cingulate (&bgr;=−0.113; p=0.032) regions in hypertensive but not normotensive subjects. In addition, low circulatory LDL‐C levels, combined with hypertension, had the lowest posterior cingulate GMV (&bgr;=−0.073; p=0.021), highest periventricular WMH (&bgr;=0.089; p=0.011) and lowest verbal memory test scores (&bgr;=−0.088; p=0.035) compared with neither low circulatory LDL‐C level nor hypertension, and either hypertension or low circulatory LDL‐C level. Age, sex, total intracranial volume, vascular risk factors, level of other circulatory lipids, and the taking of anti‐hypertensive and lipid‐lowering medications were adjusted. In conclusion, the role of circulatory LDL‐C level and its interactive effect with hypertension on brain health are firstly demonstrated. A low circulatory LDL‐C level was associated with reduced regional brain GMVs in hypertensive but not normotensive subjects. In addition, there seems a combined detrimental‐effect of low circulatory LDL‐C levels with hypertension on posterior cingulate GMV, WMH, and verbal memory. HIGHLIGHTSReduced regional grey‐matter volumes in subjects with low level of circulatory LDL cholesterol (LDL‐C).Combined effects of low circulatory LDL‐C with hypertension (HTN) on brain structures and functions.Reduced posterior cingulate grey‐matter volume in low circulatory LDL‐C combined with HTN.Combined effects also include higher white matter hyperintensities and poorer memory.

[1]  Sebastiaan Engelborghs,et al.  Effects of SolCos model-based individual reminiscence on older adults with mild to moderate dementia due to Alzheimer disease: a pilot study. , 2013, Journal of the American Medical Directors Association.

[2]  Christian Lambert,et al.  Characterising the grey matter correlates of leukoaraiosis in cerebral small vessel disease , 2015, NeuroImage: Clinical.

[3]  Zhaokai Li,et al.  Blood lipid levels, statin therapy and the risk of intracerebral hemorrhage , 2016, Lipids in Health and Disease.

[4]  M. Dichgans,et al.  Mechanisms of sporadic cerebral small vessel disease: insights from neuroimaging , 2013, The Lancet Neurology.

[5]  J. MacFall,et al.  Classification of White Matter Lesions on Magnetic Resonance Imaging in Elderly Persons , 2008, Biological Psychiatry.

[6]  Christos Davatzikos,et al.  Correlating Cognitive Decline with White Matter Lesion and Brain Atrophy Magnetic Resonance Imaging Measurements in Alzheimer's Disease. , 2015, Journal of Alzheimer's disease : JAD.

[7]  Ming-Jang Chiu,et al.  A Nationwide Survey of Mild Cognitive Impairment and Dementia, Including Very Mild Dementia, in Taiwan , 2014, PloS one.

[8]  Daniel W. Jones,et al.  Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure and evidence from new hypertension trials. , 2004, Hypertension.

[9]  Victoria J. Williams,et al.  Interindividual variation in serum cholesterol is associated with regional white matter tissue integrity in older adults , 2013, Human brain mapping.

[10]  J. Neaton,et al.  Serum cholesterol, blood pressure, cigarette smoking, and death from coronary heart disease. Overall findings and differences by age for 316,099 white men. Multiple Risk Factor Intervention Trial Research Group. , 1992, Archives of internal medicine.

[11]  A. Nissinen,et al.  Serum total cholesterol, apolipoprotein E epsilon 4 allele, and Alzheimer's disease. , 1998, Neuroepidemiology.

[12]  Leonie Lampe,et al.  Gray matter structural networks are associated with cardiovascular risk factors in healthy older adults , 2017, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[13]  L Guize,et al.  Combined effects of systolic blood pressure and serum cholesterol on cardiovascular mortality in young (<55 years) men and women. , 2002, European heart journal.

[14]  A. Cedazo-Mínguez,et al.  Plasma cholesterol and risk for late-onset Alzheimer’s disease , 2011, Expert review of neurotherapeutics.

[15]  Carole Dufouil,et al.  Plasma lipids and cerebral small vessel disease , 2014, Neurology.

[16]  Curt D. Furberg,et al.  Incidence, Manifestations, and Predictors of Brain Infarcts Defined by Serial Cranial Magnetic Resonance Imaging in the Elderly: The Cardiovascular Health Study , 2002, Stroke.

[17]  Karen Bandeen-Roche,et al.  Midlife hypertension and 20-year cognitive change: the atherosclerosis risk in communities neurocognitive study. , 2014, JAMA neurology.

[18]  Aldons J. Lusis,et al.  Atherosclerosis : Vascular biology , 2000 .

[19]  J. Hodges,et al.  Focal posterior cingulate atrophy in incipient Alzheimer's disease , 2010, Neurobiology of Aging.

[20]  Ming-Hsien Lin,et al.  Comparisons of sarcopenia defined by IWGS and EWGSOP criteria among older people: results from the I-Lan longitudinal aging study. , 2013, Journal of the American Medical Directors Association.

[21]  Qian-Li Xue,et al.  Twenty-six-year change in total cholesterol levels and incident dementia: the Honolulu-Asia Aging Study. , 2007, Archives of neurology.

[22]  G. Kinsella,et al.  Effect of age on forward and backward span tasks , 2004, Journal of the International Neuropsychological Society.

[23]  C M Burchfiel,et al.  Metabolic Cardiovascular Syndrome and Risk of Dementia in Japanese-American Elderly Men: The Honolulu-Asia Aging Study , 2000, Arteriosclerosis, thrombosis, and vascular biology.

[24]  In Chan Song,et al.  Posterior cingulate cortex atrophy and regional cingulum disruption in mild cognitive impairment and Alzheimer's disease , 2010, Neurobiology of Aging.

[25]  G. Eknoyan,et al.  Definition and classification of chronic kidney disease: a position statement from Kidney Disease: Improving Global Outcomes (KDIGO). , 2005, Kidney international.

[26]  Pesus Chou,et al.  Prevalence and Subtypes of Dementia in Taiwan: A community Survey of 5297 Individuals , 1995, Journal of the American Geriatrics Society.

[27]  Bruce Fischl,et al.  Thickness of the human cerebral cortex is associated with metrics of cerebrovascular health in a normative sample of community dwelling older adults , 2011, NeuroImage.

[28]  B. Agrell,et al.  Clock Drawing Test , 2013 .

[29]  H. Markus,et al.  Longitudinal patterns of leukoaraiosis and brain atrophy in symptomatic small vessel disease , 2016, Brain : a journal of neurology.

[30]  Owen Carmichael,et al.  White matter lesions and brain gray matter volume in cognitively normal elders , 2012, Neurobiology of Aging.

[31]  Antonio Bastone,et al.  New mutations in MAPT gene causing frontotemporal lobar degeneration: biochemical and structural characterization , 2012, Neurobiology of Aging.

[32]  Chi-Wei Huang,et al.  Validating the Chinese version of the Verbal Learning Test for screening Alzheimer’s disease , 2009, Journal of the International Neuropsychological Society.

[33]  Deborah Blacker,et al.  The Association Between Blood Pressure and Incident Alzheimer Disease: A Systematic Review and Meta-analysis , 2011, Epidemiology.

[34]  James D. Neaton,et al.  Serum Cholesterol, Blood Pressure, Cigarette Smoking, and Death From Coronary Heart Disease Overall Findings and Differences by Age for 316099 White Men , 1992 .

[35]  Sudha Seshadri,et al.  Impact of Hypertension on Cognitive Function: A Scientific Statement From the American Heart Association , 2016, Hypertension.

[36]  Ronald M Peshock,et al.  Cardiovascular Risk Factors Associated with Smaller Brain Volumes in Regions Identified as Early Predictors of Cognitive Decline. , 2016, Radiology.

[37]  Hugh S Markus,et al.  Brain Atrophy and Cerebral Small Vessel Disease: A Prospective Follow-Up Study , 2011, Stroke.

[38]  Bernhard Hemmer,et al.  An automated tool for detection of FLAIR-hyperintense white-matter lesions in Multiple Sclerosis , 2012, NeuroImage.

[39]  C. Annweiler,et al.  Blood pressure levels and brain volume reduction: a systematic review and meta-analysis , 2013, Journal of hypertension.

[40]  Karl J. Friston,et al.  Voxel-Based Morphometry—The Methods , 2000, NeuroImage.

[41]  H. Soininen,et al.  Serum cholesterol changes after midlife and late-life cognition , 2007, Neurology.

[42]  John Ashburner,et al.  A fast diffeomorphic image registration algorithm , 2007, NeuroImage.

[43]  Jennifer G. Robinson,et al.  2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. , 2014, Circulation.

[44]  James T Becker,et al.  Voxel Level Survival Analysis of Grey Matter Volume and Incident Mild Cognitive Impairment or Alzheimer's Disease. , 2015, Journal of Alzheimer's disease : JAD.

[45]  Frederik Barkhof,et al.  Progression of White Matter Hyperintensities and Incidence of New Lacunes Over a 3-Year Period: The Leukoaraiosis and Disability Study , 2008, Stroke.

[46]  G. Busatto,et al.  Neurostructural predictors of Alzheimer's disease: A meta-analysis of VBM studies , 2011, Neurobiology of Aging.

[47]  Ariadna Besga,et al.  Plasma levels of 24S-hydroxycholesterol reflect brain volumes in patients without objective cognitive impairment but not in those with Alzheimer's disease , 2009, Neuroscience Letters.

[48]  Natalia S. Rost,et al.  Hyperlipidemia and Reduced White Matter Hyperintensity Volume in Patients With Ischemic Stroke , 2010, Stroke.